About us

Working with touchscreen

About us


3D Spine Matrix researches, develops and commercializes a novel proprietary biological technology that is capable of restoring the function of damaged parts of the body through the reconstruction of structural tissue. Natural collagen can be obtained from different sources.  Everything is collagen and at first glance the same. For clinical use there is a significant importance of relying on a collagen that is as much as possible undenatured, non-allergic and free of undesirable pollutions or contaminants. The extracted collagen must continue to be crosslinked in general. This crosslinking process is generally carried out either by a physical process  or by a chemical process. Optionally, a final product can be obtained which does not retain the structure of natural collagen. Another problem of the prior art that is common is the extended extraction times required by the dialytic purification process to remove the salts used in the extraction step. Our method with collagen from hand plucked rat tails allows to overcome the disadvantages of the prior art and results in a final collagen type I that is highly pure and undenatured and therefore unique. The applications range from cartilage to all indications where collagen is found in the body. We are thinking in particular of adcanced wound healing, reconstructive medicine, in-vitro-diagnostics for cancer diagnostics and SARS-COV 2 testings as well as veterinary medicine.


Our Founders

Dr. Christian Burgard

Dr. Christian Burgard
Founder & Chief Scientific Officer

Dr. Christian Burgard has a PhD in biophysics and physical basics of medicine and has long term experience in R&D, Clinical, Medical, Regulatory Affairs. He gained his experience in the health industry at Aesculab, AAP, Stryker and Arthro-Kinetics before joining 3D Spine Matrix Biotechnology as CSO. 

Axel Krabler
Founder & Chief Executive Officer

He studied german and french law and has long term professional experience in Operating and Legal Affairs. He founded 3D Spine Matrix Biotechnology to start a revolution in spinal disc health management because he himself had a severe herniated disc in 2004 with incredible pain. In his professional career he was co-founder of 2 companies in Germany. Cooperation and Partnering with TU Munich for development of sophisticated software for key accounts of Financial Institutions and Insurance Companies (ALLIANZ, Dresdner Bank, Bayerische Vereinsbank). He was lecturer for members of the banking industry. Govermental Affairs and independent partnerships, Member of Boards and Advisory Councils. His experience in biotechnology results from his work as a legal advisor in this industry.


Share by: